Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 252-667-4 | CAS number: 35674-65-8
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- The study was conducted in a contract research organization according to internationally accepted technical guidelines then at force, but without QA-statement. The study is scientifically valid and, despite limited documentation, fully adequate for assessment.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 983
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Strain Winkelmann, Paderborn
- Age at study initiation: no data
- Weight at study initiation: 180 - 190 g
- Fasting period before study: 16 hours
- Housing: in groups of 5 males or 5 females
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: no data
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22°C +/- 1°C
- Humidity (%): 45% - 55%
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): 12 h / 1 2h
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: 1% Tylose (cellulose ether)
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: low dose: 25%, mid dose and high dose : 30%
- Amount of vehicle (if gavage):low dose: 10 ml/kg, mid dose: 17 ml/kg, high dose : 33 m l/kg - Doses:
- 2500, 5000, and 10000 mg/kg body weight
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: observations 1, 2, 7, and 14 days after application, weighing at start and on day 14
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs: appearance, behaviour, hair coat, mucosae, faeces, food and water intake
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 10 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- no death occurred
- Clinical signs:
- there were no clinical signs in any animal
- Body weight:
- no differences in body weight gain between animals of the three dose groups
- Gross pathology:
- no findings in any animal in lungs, heart, stomach, small and large intestine, liver, spleen, kidneys, blood vessels, lymphatic vessels, reproductive glands
Applicant's summary and conclusion
- Interpretation of results:
- practically nontoxic
- Remarks:
- Migrated information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
